Recent Articles

Popular Posts

Site search

Follow Us

San Diego-Based Ambrx to Collaborate with Roche

Written by on Friday, December 9th, 2005 Print This Post Print This Post

San Diego-based Ambrx, Inc., and Roche have entered into a collaboration agreement, in which Ambrx will use its proprietary technology to develop next generation proteins and peptides. The parties plan to use the technology platform to generate novel pegylated interferon alpha molecules.

The terms of the agreement provide for Roche to fund research and development of the products and to retain exclusive worldwide commercialization rights. In return, Ambrx will receive license fees, research funding, development milestone payments, and royalties on product sales. The Roche Venture Fund has also agreed to make an equity investment in Ambrx.

1,061 total views, 1 views today

Category: Biotech Deals

© 2008-2015 The Prinz Law Office. All rights reserved.

The Prinz Law Office | Silicon Valley, CA | Los Angeles, CA | Orange County, CA | San Diego, CA | Atlanta, GA | Tel: 1.800.884.2124

Mailing Address: 117 Bernal Rd., Suite 70-110, San Jose, CA 95119; Silicon Valley Office: San Jose- 2033 Gateway Place, 5th Floor, San Jose, CA 95110 (408)884-2854; Los Angeles Office: 3110 Main St., Building C, Santa Monica, CA 90405 (310)907-9218; Orange County Office: 100 Spectrum Center Drive, 9th Floor, Irvine, CA 92618 (949)236-6777; San Diego Office: 4455 Murphy Canyon Road, Suite 100, San Diego, CA 92123 (619)354-2727 Atlanta Office: 1000 Parkwood Circle, Suite 900, Atlanta, Georgia 30339 (404)479-2470

Biotech Lawyer & Attorney: Serving Silicon Valley, San Jose, San Francisco, Santa Cruz, San Diego, Los Angeles, Orange County, Irvine, Anaheim, Santa Monica, Silicon Beach, Santa Barbara, Sacramento, Atlanta. Licensed in California and Georgia.

Get every new post delivered to your Inbox

Join other followers